Where it's made
| Factory | Where | Role | Last FDA inspection |
|---|---|---|---|
| Zydus Lifesciences Limited | Ahmedabad, India | Makes it and tests it | Problems found, fixed voluntarilyJun 17, 2025 · 9 inspections, 1 with FDA action |
Recalls
- Feb 13, 2025 · Class II · Zydus Pharmaceuticals (USA) Inc
Failed Impurities/Degradation Specifications
Lots: Lot: a) P300197, Exp. Aug-2025; P400113, Exp. May-26; b) P300169, Exp. Jun-2025; P400115, Exp. May-2026.
Class I recalls are the most serious; Class III the least. A recall covers specific lots, listed on each recall.
Product details
- Generic drug
- Nelarabine: every company that makes it
- Form
- injection, intravenous
- Strength
- 5 mg per 1 mL
- Approval
- ANDA ANDA215037
- On the market since
- Jun 24, 2022
- Package NDCs
70710-1839-170710-1839-8- Official label
- DailyMed (National Library of Medicine), updated Apr 16, 2025
Got it by mail or from a pharmacy you don't know? Look the pharmacy up on Who Filled My Rx?